KKL
Click for more information
0.00% 1.5¢ kollakorn corporation limited

I have had some email exchange with Richard about a...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. whallm
    849 Posts.
    lightbulb Created with Sketch. 15
    clock Created with Sketch.
    15/04/16
    18:19
    Post #: 17516815
    I have had some email exchange with Richard about a clarrification from the AGM on the Carribean deal which hasnt progressed....i have to say he does seem extremely legitimate and have the best interests for KKL...i would consider putting my left ear on the line to suggest that he would leave KKL set up nicely....anyhow just my opinion...but i have been buying and will get slammed if my hunch is wrong.....its all about the finance and we need some news.....
    Last edited by whallm: 15/04/16
    KKL Price at posting: 0.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant resource upgrade and maiden ore reserve established, highlighting growth potential at Kanmantoo Copper Mine
right-arrow Created with Sketch.
NEWS MOU executed with leading maritime partner to advance plans for a multi-user transhipping facility in West Pilbara
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KKL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.